Vanquish Bio
PrivateTotal Funding Raised
$399,580
Company Overview
Vanquish Bio operates in Healthcare & Life Sciences and is based in Chicago, Illinois. It has raised $399,580.
Vanquish Bio is a biotechnology company developing cell-free biologic therapies derived from natural killer (NK) cell extracellular vesicles for the treatment of difficult-to-treat cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vanquish Bio Comparables
Compare Vanquish Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EV Therapeutics | 79% | |
| EviCure | 78% | |
| Taiwan Exosome Co., Ltd. | 71% |
For institutional investors. Book with your work email.
Vanquish Bio Funding Rounds
Historical fundraising activity
Vanquish Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
Vanquish Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vanquish Bio's valuation, stock price, and market status.
Is Vanquish Bio a public or private company?
Vanquish Bio is a private company.
What is the current stock price of Vanquish Bio?
Vanquish Bio is a private company, so its shares have no public market price. Caplight tracks Vanquish Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vanquish Bio worth (valuation)?
Valuation information for Vanquish Bio is not publicly available.
Can I buy Vanquish Bio stock?
Vanquish Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vanquish Bio's last funding round?
Funding round information for Vanquish Bio is not publicly available.
Who are the main investors in Vanquish Bio?
Key investors in Vanquish Bio include National Cancer Institute.
Will Vanquish Bio IPO soon?
No public IPO plans have been announced for Vanquish Bio.
How can I track Vanquish Bio secondary market activity?
Caplight tracks bids, offers, and trades in Vanquish Bio's shares on secondary markets.